BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26142905)

  • 21. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition.
    Chen H; Zhang H; Lee J; Liang X; Wu X; Zhu T; Lo PK; Zhang X; Sukumar S
    Cancer Res; 2007 Sep; 67(17):8007-13. PubMed ID: 17804711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
    Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
    BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
    Thulasiraman P; McAndrews DJ; Mohiudddin IQ
    BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
    Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
    J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
    Fettig LM; McGinn O; Finlay-Schultz J; LaBarbera DV; Nordeen SK; Sartorius CA
    Oncogene; 2017 Nov; 36(44):6074-6084. PubMed ID: 28692043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
    Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
    BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
    Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
    Zhao Z; Zhang ZP; Soprano DR; Soprano KJ
    Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular retinoic acid-binding protein 2 inhibits tumor growth by two distinct mechanisms.
    Vreeland AC; Levi L; Zhang W; Berry DC; Noy N
    J Biol Chem; 2014 Dec; 289(49):34065-73. PubMed ID: 25320093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation.
    Persaud SD; Park SW; Ishigami-Yuasa M; Koyano-Nakagawa N; Kagechika H; Wei LN
    Sci Rep; 2016 Mar; 6():22396. PubMed ID: 26935534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A specific defect in the retinoic acid response associated with human lung cancer cell lines.
    Zhang XK; Liu Y; Lee MO; Pfahl M
    Cancer Res; 1994 Nov; 54(21):5663-9. PubMed ID: 7923214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.
    Schug TT; Berry DC; Shaw NS; Travis SN; Noy N
    Cell; 2007 May; 129(4):723-33. PubMed ID: 17512406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.
    Xia SL; Wu ML; Li H; Wang JH; Chen NN; Chen XY; Kong QY; Sun Z; Liu J
    Oncotarget; 2015 Mar; 6(8):5889-902. PubMed ID: 25797252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
    Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer.
    Favorskaya I; Kainov Y; Chemeris G; Komelkov A; Zborovskaya I; Tchevkina E
    Tumour Biol; 2014 Oct; 35(10):10295-300. PubMed ID: 25034531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
    Zhu WY; Jones CS; Amin S; Matsukuma K; Haque M; Vuligonda V; Chandraratna RA; De Luca LM
    Cancer Res; 1999 Jan; 59(1):85-90. PubMed ID: 9892191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.
    Wallden B; Emond M; Swift ME; Disis ML; Swisshelm K
    BMC Cancer; 2005 Oct; 5():140. PubMed ID: 16255778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.